Oncology Patient Support Program Strategy Development

A mid-sized pharmaceutical company was preparing to launch a new physician-administered oncology product in a competitive marketplace. The company needed to develop an overarching patient support strategy (PSP) and a business case to senior leadership to support the effort.

Our team began a three-phase project to achieve the client’s objectives.  In the first phase, we benchmarked competitors’ PSP offerings, conducted secondary research to understand the rules and regulations governing PSPs in the client’s space, and ensured that the core team was aligned on its vision for PSP offerings.  The second phase involved blinded primary research with clinic oncology practice managers (OPMs) to understand their perceptions of manufacturer-offered PSPs, gather their input regarding PSP operationalization, and identify additional services beneficial to the clinics and their patients. Finally, our team synthesized the findings to develop a PSP strategy and a strategic business case which was presented to senior leadership to support the patient support program investment.

The client received a sound, well-informed strategy, that when shared with senior leadership presented a clear business case for the PSP vision, investment and green light to move forward to launch with confidence.